Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BT8009
BT8009
ASCO-GU – Bicycle tries to put distance between itself and Seagen
EP Vantage
Thu, 02/16/23 - 10:15 am
ASCO-GU
Bicycle Therapeutics
Seagen
Padcev
urothelial cancer
BT8009
Bicycle Therapeutics shares fall 23% after the company shares interim Phase 1 data
Marketwatch
Mon, 04/11/22 - 10:39 am
AACR
Bicycle Therapeutics
clinical trials
urothelial cancer
BT8009